Powl Brian T. - 27 Jan 2026 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Commercial Officer
Signature
Teresa Bair, Attorney-in-fact for Brian Powl
Issuer symbol
KURA
Transactions as of
27 Jan 2026
Net transactions value
-$54,266
Form type
4
Filing time
27 Jan 2026, 21:35:08 UTC
Previous filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Powl Brian T. Chief Commercial Officer C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO Teresa Bair, Attorney-in-fact for Brian Powl 27 Jan 2026 0001934232

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale $40,966 -4,842 -2.6% $8.46 184,847 27 Jan 2026 Direct F1
transaction KURA Common Stock Sale $13,300 -1,572 -0.85% $8.46 183,275 27 Jan 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25.
F2 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.